Inrebic
- Product NDC
- 59572-720
- 11-digit product format
- 595720720
- Labeler code
- 59572
- Product ID
- 59572-720_4707dba8-73ee-4119-805b-65c3f3a55b72
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Fedratinib Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Celgene Corporation
- Application
- NDA212327
- Marketing category
- NDA
- Marketing start
- 2019-08-16
- Substance
- FEDRATINIB HYDROCHLORIDE
- Active strength
- 100 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Inrebic
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| FEDRATINIB HYDROCHLORIDE | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | UH9J2HBQWJ |
| Rxcui | 2197495, 2197501 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 59572-720-12 | Inrebic | 120 in 1 BOTTLE, PLASTIC | CAPSULE | 120 | | 11 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 59572-720 | INREBIC (FEDRATINIB HYDROCHLORIDE) CAPSULE [CELGENE CORPORATION] | 10 | Current NDC, Legacy NDC, 1 package rows | 20250524_f0f55a2a-4e0c-4cba-8571-03e1424486d7.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 59572-720-12 | 59572072012 | 120 CAPSULE in 1 BOTTLE, PLASTIC (59572-720-12) | 120 capsule | 2019-08-16 | 0000-00-00 | No | No | Current |